Apart from their role in CRPC, glucocorticoids can also contribute to treatment failure in many other cancer types.[45,46] Understanding the tumorigenic effects of GR activation in other tumor types might provide useful insights and generate interesting hypotheses regarding the effects of GR in prostate cancer. Here, NR3C1 is linked to Familial prostate cancer.